TissueScan Citations

OriGene products have been used extensively by scientists worldwide to improve their research efficiency. For your reference, we have collected a representation of citations for selected OriGene products and posted them at this site.

Search citations by gene symbols or target names

Here are some of the recent papers making use of OriGene products by fellow researchers.

Target Research Paper Journal Product SKU
Ovarian Cancer PRSS21/testisin inhibits ovarian tumor metastasis and antagonizes proangiogenic angiopoietins ANG2 and ANGPTL4 J. Mol. Med., 2019 Mar TissueScan HORT502
Ovarian Cancer Inhibition of Transient Receptor Potential Vanilloid 6 channel, elevated in human ovarian cancers, reduces tumour growth in a xenograft model J. Cancer, 2018 Aug TissueScan HORT101
Ovarian Cancer Inhibition of Transient Receptor Potential Vanilloid 6 channel, elevated in human ovarian cancers, reduces tumour growth in a xenograft model J. Cancer, 2018 Aug TissueScan HORT102
Ovarian Cancer Inhibition of Transient Receptor Potential Vanilloid 6 channel, elevated in human ovarian cancers, reduces tumour growth in a xenograft model J. Cancer, 2018 Aug TissueScan HORT103
Ovarian Cancer Inhibition of Transient Receptor Potential Vanilloid 6 channel, elevated in human ovarian cancers, reduces tumour growth in a xenograft model J. Cancer, 2018 Aug TissueScan HORT104
Ovarian Cancer Identification of cancer biomarkers of prognostic value using specific gene regulatory networks (GRN): a novel role of RAD51AP1 for ovarian and lung cancers Carcinogenesis, 2018 Mar TissueScan HORT101
Ovarian Cancer CIB2 negatively regulates oncogenic signaling in ovarian cancer via sphingosine kinase 1 Cancer Res., 2017 Jul TissueScan HORT302
Ovarian Cancer Dual Targeting of Epithelial Ovarian Cancer Via Folate Receptor α and the Proton-Coupled Folate Transporter with 6-Substituted Pyrrolo[2,3-d]pyrimidine Antifolates Mol. Cancer Ther., 2017 May TissueScan HORT301
Ovarian Cancer Array 1 The Lymphotactin Receptor Is Expressed in Epithelial Ovarian Carcinoma and Contributes to Cell Migration and Proliferation Mol. Cancer Res., Nov 2012; 10: 1419 - 1429., 2012 Nov TissueScan HORT101
Ovarian Cancer cDNA Array I Matrix Rigidity Activates Wnt Signaling through Down-regulation of Dickkopf-1 Protein J. Biol. Chem., Jan 2013; 288: 141 - 151., 2013 Jan TissueScan HORT101
Ovarian Cancer Panel I Analysis of the levels of lysine-specific demethylase 1 (LSD1) mRNA in human ovarian tumors and the effects of chemical LSD1 inhibitors in ovarian cancer cell lines J Ovarian Res. 2013 Oct 29;6(1):75, 2013 Oct TissueScan HORT101
Ovarian Cancer Panel I YPEL3, a p53-Regulated Gene that Induces Cellular Senescence Cancer Res., May 2010; 70: 3566 - 3575, 2010 May TissueScan
Ovarian Cancer Panels Regulation of Ovarian Cancer Cell Viability and Sensitivity to Cisplatin by Progesterone Receptor Membrane Component-1 J. Clin. Endocrinol. Metab., May 2008; 93: 1592 - 1599., 2008 May TissueScan
Ovarian Cancer Panels KLF8 transcription factor participates in oncogenic transformation Oncogene. 2007 Jan 18;26(3):456-61., 2007 Jan TissueScan
Ovarian Cancer Tissue Panel II Expression, regulation and clinical relevance of the ATPase inhibitory factor 1 in human cancers Oncogenesis 2, e46 doi:10.1038/oncsis.2013.9, 2013 Apr TissueScan HORT102
Ovarian Carcinoma Panel I Microenvironmental Regulation of Chemokine (C-X-C-Motif) Receptor 4 in Ovarian Carcinoma Mol. Cancer Res., May 2010; 8: 653 - 664, 2010 May TissueScan
Pancreatic Cancer Diphenylbutylpiperidine Antipsychotic Drugs Inhibit Prolactin Receptor Signaling to Reduce Growth of Pancreatic Ductal Adenocarcinoma in Mice Gastroenterology, 2019 Nov TissueScan PNRT301
Pancreatic Cancer qPCR Panel 1 Targeting Inhibitors of the Tumor Suppressor PP2A for the Treatment of Pancreatic Cancer Mol. Cancer Res., 2014 Mar TissueScan PNRT301
PNRT301 Loss of SOD3 (EcSOD) expression promotes an aggressive phenotype in human pancreatic ductal adenocarcinoma Clin. Cancer Res., 2015 Jan TissueScan PNRT301
Prostate Cancer The role of opiorphin genes in prostate cancer growth and progression Future oncology (London, England) 2021, 2021 Feb TissueScan HPRT103
Prostate Cancer Phosphodiesterase SMPDL3B Gene Expression as Independent Outcome Prediction Marker in Localized Prostate Cancer Int J Mol Sci, 2020 Jun TissueScan HPRT102
Prostate Cancer Histone Demethylase KDM4C Stimulates the Proliferation of Prostate Cancer Cells via Activation of AKT and c-Myc Cancers (Basel) 2019, 2019 Nov TissueScan HPRT501
Prostate Cancer Histone Demethylase KDM4C Stimulates the Proliferation of Prostate Cancer Cells via Activation of AKT and c-Myc Cancers (Basel) 2019, 2019 Nov TissueScan HPRT502
Prostate Cancer Histone Demethylase KDM4C Stimulates the Proliferation of Prostate Cancer Cells via Activation of AKT and c-Myc Cancers (Basel) 2019, 2019 Nov TissueScan HPRT503
Prostate Cancer TRPM4 channel is involved in regulating epithelial to mesenchymal transition, migration, and invasion of prostate cancer cell lines J. Cell. Physiol., 2018 Oct TissueScan HPRT302
Prostate Cancer ASPM promotes prostate cancer stemness and progression by augmenting Wnt-Dvl-3-β-catenin signaling Oncogene, 2018 Sep TissueScan HPRT102
Prostate Cancer ASPM promotes prostate cancer stemness and progression by augmenting Wnt-Dvl-3-β-catenin signaling Oncogene, 2018 Sep TissueScan HPRT103
Prostate Cancer AT-rich interactive domain 5B regulates androgen receptor transcription in human prostate cancer cells Prostate, 2018 Jul TissueScan HPRT102
Prostate Cancer BRCA1 Interacting Protein COBRA1 Facilitates Adaptation to Castrate-Resistant Growth Conditions Int J Mol Sci, 2018 Jul TissueScan HPRT303
Prostate Cancer Role of WNT5A receptors FZD5 and RYK in prostate cancer cells Oncotarget, 2018 Jun TissueScan HPRT103
Prostate Cancer Mineralocorticoid receptor signaling affects therapeutic effect of enzalutamide Prostate, 2018 May TissueScan HPRT303
Prostate Cancer TRAF4-mediated ubiquitination of NGF receptor TrkA regulates prostate cancer metastasis J. Clin. Invest., 2018 May TissueScan HPRT103
Prostate Cancer A Panel of Biomarkers for Diagnosis of Prostate Cancer Using Urine Samples Anticancer Res., 2018 Mar TissueScan HPRT301
Prostate Cancer Inhibition of cyclooxygenase-2-mediated matriptase activation contributes to the suppression of prostate cancer cell motility and metastasis Oncogene, 2017 Apr TissueScan HPRT103
Prostate Cancer Androgen Mediated Regulation of Endoplasmic Reticulum-Associated Degradation and its Effects on Prostate Cancer Sci Rep, 2017 Jan TissueScan HPRT503
Prostate Cancer ZFP91: A Noncanonical NF-?B Signaling Pathway Regulator with Oncogenic Properties Is Overexpressed in Prostate Cancer Biomed Res Int, 2016 Dec TissueScan HPRT103
Prostate Cancer Inherited Variants in Wnt Pathway Genes Influence Outcomes of Prostate Cancer Patients Receiving Androgen Deprivation Therapy Int J Mol Sci, 2016 Nov TissueScan HPRT102
Prostate Cancer Prognostic Relevance of Methylenetetrahydrofolate Reductase Polymorphisms for Prostate Cancer Int J Mol Sci, 2016 Nov TissueScan HPRT103
Prostate Cancer cDNA Array I A FTH1 gene:pseudogene:microRNA network regulates tumorigenesis in prostate cancer Nucleic Acids Res., 2017 Dec TissueScan HPRT301
Prostate Cancer cDNA Array II Proteomic Profiling of Androgen-independent Prostate Cancer Cell Lines Reveals a Role for Protein S during the Development of High Grade and Castration-resistant Prostate Cancer J. Biol. Chem., Oct 2012; 287: 34019 - 34031., 2012 Oct TissueScan
Prostate Cancer cDNA Array III Prostaglandin receptor EP3 mediates growth inhibitory effect of aspirin through androgen receptor and contributes to castration resistance in prostate cancer cells Endocr. Relat. Cancer, May 2013; 20: 431 - 441., 2013 May TissueScan HPRT303
Prostate Cancer cDNA Array III FGF-2 Disrupts Mitotic Stability in Prostate Cancer through the Intracellular Trafficking Protein CEP57 Cancer Res., Feb 2013; 73: 1400 - 1410., 2013 Feb TissueScan HPRT103
Prostate Cancer HPRT101 Elevation of androgen receptor promotes prostate cancer metastasis by induction of epithelial-mesenchymal transition and reduction of KAT5 Cancer Sci., 2018 Nov TissueScan HPRT101
Prostate Cancer HPRT101 Elevation of androgen receptor promotes prostate cancer metastasis by induction of epithelial-mesenchymal transition and reduction of KAT5 Cancer Sci., 2018 Nov TissueScan HPRT102
Prostate Cancer HPRT101 Elevation of androgen receptor promotes prostate cancer metastasis by induction of epithelial-mesenchymal transition and reduction of KAT5 Cancer Sci., 2018 Nov TissueScan HPRT103
Prostate Cancer Panel EBP1, an ErbB3-binding protein, is decreased in prostate cancer and implicated in hormone resistance Mol. Cancer Ther., Oct 2008; 7: 3176 - 3186, 2008 Oct TissueScan
Prostate Cancer Panel I Increased expression of CYP24A1 correlates with advanced stages of prostate cancer and can cause resistance to vitamin D3-based therapies FASEB J. 2013 Nov 7, 2013 Nov TissueScan HPRT101
prostate cancer panel I MicroRNAs 221/222 and Genistein-Mediated Regulation of ARHI Tumor Suppressor Gene in Prostate Cancer Cancer Prevention Research, Jan 2011; 4: 76 - 86, 2011 Jan TissueScan
Prostate Cancer Panel II The Stress Response Mediator ATF3 Represses Androgen Signaling by Binding the Androgen Receptor Mol. Cell. Biol., Aug 2012; 32: 3190 - 3202., 2012 Aug TissueScan HPRT102
Prostate Cancer qPCR Array Panel I The role of sLZIP in cyclin D3-mediated negative regulation of androgen receptor transactivation and its involvement in prostate cancer Oncogene, Jan 2014., 2014 Jan TissueScan HPRT101